Joshua Kantrowitz, MD
Enriched profileProfessor of Clinical Psychiatry · Columbia University Department of Psychiatry
Joshua Kantrowitz is Professor of Clinical Psychiatry at Columbia University Department of Psychiatry. OpenAlex indexes 126 publications with 5,031 citations (h-index 38); ClinicalTrials.gov lists 6 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Joshua Tolkien Kantrowitz, MD, is Professor of Clinical Psychiatry at Columbia University Department of Psychiatry / New York State Psychiatric Institute. The public record shows 126 publications with 5,031 citations (h-index 38), centered on Bipolar Disorder, Schizophrenia. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 7 companies, 5 NIH-funded awards (2015–2026).
- Most recent indexed publication: 2026 · Neuropsychopharmacology
- Top research focus: Bipolar Disorder
- 6 registered trials on ClinicalTrials.gov
- Open Payments reporting from 7 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 18 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:
- A PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia
Sponsor: New York State Psychiatric Institute
- Glutamatergic Mechanisms: Aim2
Sponsor: New York State Psychiatric Institute
- D-serine and Cognitive Remediation in Schizophrenia
Sponsor: Nathan Kline Institute for Psychiatric Research
Industry payments
Updated 27 Aug 2026
7 companies reported payments to CMS in program years 2022–2025. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20257 payments
- ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)Program year20251 payment
- Neurocrine Biosciences, Inc.Program year202315 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Atypical Antipsychotic39%Olanzapine100%Part D<11 patientsAntihistamine15.6%Benztropine Mesylate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
5 NIH research awards on record, funded 2015–2026 per NIH RePORTER. The latest:
- Decoded fMRI neurofeedback for auditory verbal hallucinations in schizophrenia
Columbia University Health Sciences
FY2026$1,542,242R61MH143195 - D-serine augmentation of neuroplasticity-based auditory learning in schizophrenia
New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, Inc
FY2023$142,153R33MH116093 - Glutamatergic mechanisms of psychosis and target engagement
New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, Inc
FY2022$717,908R01MH123142
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Feasibility of a digital therapeutic for experiential negative symptoms of schizophrenia: results from an exploratory study.
Schizophrenia (Heidelberg, Germany)
Article2025 - Assessing the inter-rater reliability of the Schizophrenia Cognition Rating Scale: a non-interventional quantitative study.
Schizophrenia (Heidelberg, Germany)
Article2025
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/joshua-kantrowitz-md-49e858a6
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/dr-joshua-kantrowitz-0880a45
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
State University of New York Downstate Health Sciences Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →columbiapsychiatry.org ↗ - Psychiatry Residency
Yale-New Haven Hospital
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →columbiapsychiatry.org ↗ - Fellowship
New York State Psychiatric Institute
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →columbiapsychiatry.org ↗ - Board Certified
Psychiatry (American Board of Psychiatry and Neurology)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
Editorial & leadership roles
journal and society appointments- Co-Editor
Handbook of Neurochemistry and Molecular Neurobiology: Schizophrenia (with Daniel C. Javitt and Abel Lajtha)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psychiatry.ru ↗
Awards & honors
honors on the public record- Young Investigator Travel Award
Schizophrenia International Research Biennial Conference, Florence, Italy
2012verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nki.rfmh.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nki.rfmh.org ↗
Secondary affiliations
appointments beyond the home institution- Nathan Kline Institute for Psychiatric Research
Research Scientist, Schizophrenia Research
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nki.rfmh.org ↗ - Director
Lieber Research Clinic, New York State Psychiatric Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nki.rfmh.org ↗ - Director
Columbia Schizophrenia Research Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →columbiapsychiatry.org ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psychiatrist.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.